研究發(fā)現(xiàn)DMP1蛋白具抗血管生成作用(3)
2011-01-27 10:57
閱讀:3900
來源:愛愛醫(yī)編輯部
作者:水**南
責(zé)任編輯:水北天南
[導(dǎo)讀] 一個來自GIGA-Cancer/Liège大學(xué)醫(yī)院的研究隊伍在《血液》剛剛出版的期刊上發(fā)表文章稱,他們新發(fā)現(xiàn)了牙本質(zhì)基質(zhì)蛋白具有抗血管生成的作用,這在以前沒有發(fā)現(xiàn)過
But Doctor Akeila Bellahcène's most recent research demonstrates that DMP1 also deserves very special attention. In effect the results published in the journal Blood show that DMP1 is capable of blocking angiogenesis. Yet angiogenesis is vital for the development of tumours beyond a few cubic millimetres, as well as for the formation of metastases.
The work shows that DMP1 prevents endothelial cells (the cells which form new blood vessels over the course of angiogenesis) to respond to VEGF, a molecular signal sent by cancer cells to activate the formation of new feeder blood vessels. The presence of DMP1 halts the different stages which lead to the formation of new capillaries: the endothelial cells are placed in a resting non proliferative state.
"In an in vivo model of angiogenesis linked to tumour development, we have shown that the tumours from cancer cells in which we had beforehand overexpressed DMP1 had a reduced growth combined with very modest vascularisation in comparison with the control tumours," points out Doctor Bellahcène.
版權(quán)聲明:
本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net,我們將立即進行刪除處理